CRISPR Therapeutics AG (CRSP)
39.53
1.17 (3.05%)
At close: Jan 15, 2025, 1:24 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Net Income | -153.61M | -650.17M | 377.66M | -348.87M | 66.86M | -164.98M | -68.36M | -23.20M | -25.83M | -6.80M |
| Depreciation & Amortization | 19.84M | 24.17M | 17.95M | 9.18M | 4.72M | 3.52M | 3.02M | 925.00K | 127.00K | 38.00K |
| Stock-Based Compensation | 81.03M | 97.95M | 102.39M | 66.02M | 44.06M | 34.98M | 18.87M | 10.84M | 3.68M | 695.00K |
| Other Working Capital | 3.33M | 14.38M | 27.02M | 33.48M | -48.42M | -1.00M | -21.24M | 1.83M | 81.71M | 1.53M |
| Other Non-Cash Items | -14.04M | 12.47M | 14.11M | 1.86M | -10.53M | 15.41M | 1.75M | 8.05M | 97.00K | -260.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 4.28M | n/a | -53.71M | -20.00K | n/a |
| Change in Working Capital | -193.59M | 19.84M | 26.86M | 33.44M | -48.43M | 10.55M | -25.39M | 1.78M | 81.37M | 1.53M |
| Operating Cash Flow | -260.38M | -495.74M | 538.97M | -238.37M | 56.68M | -96.24M | -70.10M | -55.31M | 59.43M | -4.79M |
| Capital Expenditures | -11.97M | -37.19M | -81.70M | -18.36M | -6.68M | -2.77M | -7.81M | -3.02M | -1.15M | n/a |
| Acquisitions | n/a | 221.47M | 953.73M | 522.81M | 8.01M | n/a | n/a | -100.00K | n/a | n/a |
| Purchase of Investments | -1.07B | -1.42B | -1.51B | -594.00M | n/a | n/a | -500.00K | -100.00K | n/a | n/a |
| Sales Maturities Of Investments | 1.45B | 1.20B | 555.60M | 71.19M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -2.50M | -221.47M | -953.73M | -522.81M | 8.01M | n/a | -500.00K | 35.00M | n/a | n/a |
| Investing Cash Flow | 374.65M | -258.65M | -1.04B | -541.17M | 1.32M | -2.77M | -8.31M | 31.88M | -1.15M | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 35.01M | 38.24M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -57.00K | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 29.94M | 37.62M | 37.68M | 33.86M | 15.96M | 8.94M | 2.61M | 59.15M | 58.49M | 5.10M |
| Financial Cash Flow | 62.66M | 38.59M | 250.94M | 1.02B | 430.98M | 315.93M | 2.61M | 183.22M | 96.73M | 5.12M |
| Net Cash Flow | 177.01M | -715.88M | -245.52M | 236.66M | 489.00M | 216.90M | -75.76M | 159.56M | 155.02M | 584.00K |
| Free Cash Flow | -272.35M | -532.93M | 457.27M | -256.72M | 49.99M | -99.01M | -77.91M | -58.33M | 58.27M | -4.79M |